Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
102318268 | 10231826 | 8 | F | 2015 | 20160809 | 20140612 | 20160811 | EXP | CA-ROCHE-1408821 | ROCHE | 0.00 | F | Y | 95.00000 | KG | 20160811 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
102318268 | 10231826 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 800 | MG | SOLUTION FOR INFUSION | ||||||||
102318268 | 10231826 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 787 | MG | SOLUTION FOR INFUSION | ||||||||
102318268 | 10231826 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 796 | MG | SOLUTION FOR INFUSION | ||||||||
102318268 | 10231826 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 794 | MG | SOLUTION FOR INFUSION | ||||||||
102318268 | 10231826 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | LAST DOSE PRIOR TO CELLULITIS | 125276 | SOLUTION FOR INFUSION | |||||||||
102318268 | 10231826 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 760 | MG | SOLUTION FOR INFUSION | ||||||||
102318268 | 10231826 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 794 | MG | SOLUTION FOR INFUSION | ||||||||
102318268 | 10231826 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||||
102318268 | 10231826 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
102318268 | 10231826 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
102318268 | 10231826 | 11 | C | TIAZAC (CANADA) | 2 | 0 | |||||||||||||
102318268 | 10231826 | 12 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
102318268 | 10231826 | 13 | C | DIGOXIN. | DIGOXIN | 1 | 0 | ||||||||||||
102318268 | 10231826 | 14 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
102318268 | 10231826 | 15 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
102318268 | 10231826 | 16 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 0 | 12.5 | MG | /wk | ||||||||
102318268 | 10231826 | 17 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
102318268 | 10231826 | 1 | Rheumatoid arthritis |
102318268 | 10231826 | 8 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
102318268 | 10231826 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
102318268 | 10231826 | Cellulitis | |
102318268 | 10231826 | Dysphagia | |
102318268 | 10231826 | Limb mass | |
102318268 | 10231826 | Lower respiratory tract infection | |
102318268 | 10231826 | Sinusitis | |
102318268 | 10231826 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
102318268 | 10231826 | 1 | 20110811 | 0 | ||
102318268 | 10231826 | 2 | 20110908 | 0 | ||
102318268 | 10231826 | 3 | 20121105 | 0 | ||
102318268 | 10231826 | 4 | 20140214 | 0 | ||
102318268 | 10231826 | 5 | 20141007 | 0 | ||
102318268 | 10231826 | 6 | 20150427 | 0 | ||
102318268 | 10231826 | 7 | 20150527 | 20150625 | 0 | |
102318268 | 10231826 | 8 | 2015 | 0 |